|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-8-8
|
|
pubmed:abstractText |
It is not clear whether survival times of patients with hepatocellular carcinoma (HCC) are associated with their response to therapy. We analyzed the association between tumor response and survival times of patients with HCC who were treated with locoregional therapies (LRTs) (chemoembolization and radioembolization).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1528-0012
|
|
pubmed:author |
pubmed-author:AbecassisMichaelM,
pubmed-author:BakerTaliaT,
pubmed-author:BensonAl BAB3rd,
pubmed-author:GatesVanessa LVL,
pubmed-author:GuptaRamonaR,
pubmed-author:KulikLauraL,
pubmed-author:LewandowskiRobert JRJ,
pubmed-author:MarshallKarenK,
pubmed-author:MemonKhairuddinK,
pubmed-author:MillerFrank HFH,
pubmed-author:MulcahyMary FMF,
pubmed-author:NikolaidisPaulP,
pubmed-author:OmaryReed ARA,
pubmed-author:RiazAhsunA,
pubmed-author:RyuRobert KRK,
pubmed-author:SalemRiadR,
pubmed-author:SatoKent TKT,
pubmed-author:SenthilnathanSeanthanS,
pubmed-author:WangEdwardE,
pubmed-author:YaghmaiVahidV
|
|
pubmed:copyrightInfo |
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
526-35, 535.e1-2
|
|
pubmed:meshHeading |
pubmed-meshheading:21664356-Aged,
pubmed-meshheading:21664356-Carcinoma, Hepatocellular,
pubmed-meshheading:21664356-Chemoembolization, Therapeutic,
pubmed-meshheading:21664356-Contrast Media,
pubmed-meshheading:21664356-Disease Progression,
pubmed-meshheading:21664356-Female,
pubmed-meshheading:21664356-Humans,
pubmed-meshheading:21664356-Liver Neoplasms,
pubmed-meshheading:21664356-Magnetic Resonance Imaging,
pubmed-meshheading:21664356-Male,
pubmed-meshheading:21664356-Middle Aged,
pubmed-meshheading:21664356-Survival Analysis,
pubmed-meshheading:21664356-Tomography, X-Ray Computed,
pubmed-meshheading:21664356-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.
|
|
pubmed:affiliation |
Department of Radiology, Section of Interventional Radiology, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
